| 发明名称 | Pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease | ||
| 摘要 | The present invention provides a pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease, comprising 50 to 90% by weight of Cordyceps sinensis mycelium powder, and 10 to 50% by weight of condensed astragalus powder. | ||
| 申请公布号 | US8858954(B2) | 申请公布日期 | 2014.10.14 |
| 申请号 | US201414151001 | 申请日期 | 2014.01.09 |
| 申请人 | TCM Biotech International Corp. | 发明人 | Hsu Huan Ching;Wang Ya Chun |
| 分类号 | A61K36/481;A61K36/068;A61K36/00;A61K36/06;A61K36/062 | 主分类号 | A61K36/481 |
| 代理机构 | Woodard, Emhardt, Moriarty, McNett & Henry LLP | 代理人 | Woodard, Emhardt, Moriarty, McNett & Henry LLP |
| 主权项 | 1. A method for treating liver fibrosis, comprising administering to a patient having liver fibrosis, a composition comprising 50 to 90% by weight of Cordyceps sinensis mycelium, and 10 to 50% by weight of astragalus. | ||
| 地址 | Neihu District, Taipei TW | ||